J CLIN TRANSL HEPATO 潤色咨詢

Journal of Clinical and Translational Hepatology

出版年份:2014 年文章數(shù):540 投稿命中率: 開通期刊會員,數(shù)據(jù)隨心看

出版周期:季刊 自引率:暫無數(shù)據(jù) 審稿周期: 開通期刊會員,數(shù)據(jù)隨心看

前往期刊查詢

投稿信息

投稿信息
審稿費用
暫無數(shù)據(jù)
版面費用
暫無數(shù)據(jù)
中國人發(fā)表比例
2023年中國人文章占該期刊總數(shù)量65.16% (2022年為66.39%)
自引率
暫無數(shù)據(jù)
年文章數(shù)
540
期刊官網(wǎng)
點擊查看 (點擊次數(shù):2568)
投稿鏈接
點擊查看 (點擊次數(shù):1835次)
作者需知
點擊查看 (點擊次數(shù):704次)
期刊簡介
稿件收錄要求

Journal of Clinical and Translational Hepatology?(JCTH)?publishes high quality, peer-reviewed studies in the clinical and basic human health sciences of liver diseases. JCTH has established high standards for publication of original research characterized by a study’s novelty, quality, and ethical conduct in the scientific process, as well as in the communication of the research findings. Each issue includes review articles by leading authorities on topics in hepatology that are germane to the most current challenges in the field. Special features include reports on the latest advances in drug development and technology that are relevant to liver diseases. Regular features of the JCTH also include editorials, correspondence, and invited commentaries on rapidly progressing areas in hepatology. All articles published by the JCTH, both solicited and unsolicited, must pass a rigorous peer review.?

The open-access publishing model of JCTH avails an international readership, prompting worldwide interest from contributing authors, and helping promote the diverse range of hepatology topics covered in our journal. The JCTH welcomes submissions of articles within its topical scope including:

  • Novel discoveries in clinical and basic hepatology
  • Liver disease mechanisms
  • Novel techniques in research and management of liver diseases
  • Epidemiological/environmental factors of liver diseases
  • Role of immune system function in liver diseases
  • Acute and chronic hepatitis
  • Cirrhosis
  • Genetic and metabolic liver diseases and their complications
  • Hepatobiliary diseases
  • Liver cancer
  • Drug metabolism
  • Biliary disease
  • Peritoneal tuberculosis